Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 15.2
(-4.94%)
INR 15.2
(-4.94%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 745.72 Million INR | 26.75% |
| 2022 | 588.33 Million INR | 187.19% |
| 2021 | 204.86 Million INR | 82.97% |
| 2020 | 111.96 Million INR | -5.49% |
| 2019 | 118.46 Million INR | 109.31% |
| 2018 | 56.59 Million INR | 5.91% |
| 2017 | 53.44 Million INR | 4.03% |
| 2016 | 51.37 Million INR | 6.46% |
| 2015 | 48.25 Million INR | 87.35% |
| 2014 | 25.75 Million INR | -41.88% |
| 2013 | 44.31 Million INR | -14.15% |
| 2012 | 51.61 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 31.78 Million INR | -56.41% |
| 2023 Q3 | 188.9 Million INR | -23.33% |
| 2023 FY | 745.72 Million INR | 26.75% |
| 2023 Q1 | 201.6 Million INR | -56.41% |
| 2023 Q2 | 246.38 Million INR | 22.21% |
| 2023 Q4 | 108.83 Million INR | -42.38% |
| 2022 Q1 | 65.65 Million INR | -43.66% |
| 2022 FY | 588.33 Million INR | 187.19% |
| 2022 Q2 | 37.2 Million INR | -43.33% |
| 2022 Q4 | 462.45 Million INR | 1909.38% |
| 2022 Q3 | 23.01 Million INR | -38.14% |
| 2021 Q2 | 29.83 Million INR | 0.71% |
| 2021 Q4 | 116.53 Million INR | 303.53% |
| 2021 Q3 | 28.87 Million INR | -3.19% |
| 2021 Q1 | 29.62 Million INR | -30.5% |
| 2021 FY | 204.86 Million INR | 82.97% |
| 2020 Q4 | 42.61 Million INR | 2.71% |
| 2020 Q1 | 11.08 Million INR | -72.52% |
| 2020 FY | 111.96 Million INR | -5.49% |
| 2020 Q2 | 16.76 Million INR | 51.14% |
| 2020 Q3 | 41.49 Million INR | 147.57% |
| 2019 Q3 | 38.8 Million INR | 161.04% |
| 2019 FY | 118.46 Million INR | 109.31% |
| 2019 Q1 | 10.43 Million INR | -59.95% |
| 2019 Q4 | 40.35 Million INR | 4.01% |
| 2019 Q2 | 14.86 Million INR | 42.47% |
| 2018 FY | 56.59 Million INR | 5.91% |
| 2018 Q4 | 26.05 Million INR | 127.78% |
| 2018 Q3 | 11.43 Million INR | 32.5% |
| 2018 Q2 | 8.63 Million INR | -17.6% |
| 2018 Q1 | 10.47 Million INR | 3.55% |
| 2017 Q1 | 10.08 Million INR | -50.62% |
| 2017 Q2 | 575 Thousand INR | -94.3% |
| 2017 Q3 | 32.84 Million INR | 5612.17% |
| 2017 Q4 | 10.11 Million INR | -69.2% |
| 2017 FY | 53.44 Million INR | 4.03% |
| 2016 Q4 | 20.41 Million INR | 53.59% |
| 2016 FY | 51.37 Million INR | 6.46% |
| 2016 Q3 | 13.29 Million INR | 242.63% |
| 2016 Q2 | 3.88 Million INR | -58.55% |
| 2016 Q1 | 9.36 Million INR | -58.17% |
| 2015 FY | 48.25 Million INR | 87.35% |
| 2015 Q4 | 22.37 Million INR | 511.7% |
| 2015 Q3 | 3.65 Million INR | -60.34% |
| 2015 Q2 | 9.22 Million INR | 15.29% |
| 2015 Q1 | 8 Million INR | 141.02% |
| 2014 Q1 | 7.54 Million INR | -50.8% |
| 2014 Q3 | 3.84 Million INR | -64.9% |
| 2014 FY | 25.75 Million INR | -41.88% |
| 2014 Q4 | 3.31 Million INR | -13.58% |
| 2014 Q2 | 10.94 Million INR | 45.02% |
| 2013 Q3 | 11.77 Million INR | 25.55% |
| 2013 Q2 | 9.37 Million INR | 23.42% |
| 2013 Q1 | 7.59 Million INR | -51.08% |
| 2013 FY | 44.31 Million INR | -14.15% |
| 2013 Q4 | 15.33 Million INR | 30.32% |
| 2012 Q3 | 11.3 Million INR | -45.98% |
| 2012 FY | 51.61 Million INR | 0.0% |
| 2012 Q2 | 20.92 Million INR | 520.43% |
| 2012 Q1 | 3.37 Million INR | -20.51% |
| 2012 Q4 | 15.52 Million INR | 37.35% |
| 2011 Q2 | 17.81 Million INR | 0.0% |
| 2011 Q3 | 12.01 Million INR | -32.57% |
| 2011 Q4 | 4.24 Million INR | -64.67% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 48.961% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 63.098% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Beryl Drugs Limited | 271.24 Million INR | -174.926% |
| Cian Healthcare Limited | 616.95 Million INR | -20.873% |
| Colinz Laboratories Limited | 70.29 Million INR | -960.841% |
| Concord Drugs Limited | 449.24 Million INR | -65.996% |
| Deccan Health Care Limited | 597.28 Million INR | -24.852% |
| Gennex Laboratories Limited | 867.14 Million INR | 14.002% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -55.442% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -391.012% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 27.13% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 75.723% |
| Mercury Laboratories Limited | 755.59 Million INR | 1.305% |
| Panchsheel Organics Limited | 1.05 Billion INR | 29.126% |
| Parmax Pharma Limited | 154.24 Million INR | -383.475% |
| Parnax Lab Limited | 1.88 Billion INR | 60.483% |
| Patidar Buildcon Limited | 2.3 Million INR | -32210.615% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -393.465% |
| Phaarmasia Limited | 305.93 Million INR | -143.756% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -10.838% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 94.501% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -86.326% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -173.193% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 83.912% |
| Sunil Healthcare Limited | 901.91 Million INR | 17.318% |
| Syschem (India) Limited | 2.33 Billion INR | 68.067% |
| Trident Lifeline Limited | 446.28 Million INR | -67.097% |
| Transchem Limited | 4.09 Million INR | -18088.517% |
| Tyche Industries Limited | 696.83 Million INR | -7.016% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 40.537% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -101.448% |
| Zenith Healthcare Limited | 144.71 Million INR | -415.302% |
| Zenotech Laboratories Limited | 368.08 Million INR | -102.595% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -7009.267% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 28.895% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -3956.844% |
| MedPlus Health Services Limited | 56.24 Billion INR | 98.674% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -38.903% |
| Smruthi Organics Limited | 1.27 Billion INR | 41.577% |
| Trimurthi Limited | 42.23 Million INR | -1665.541% |
| Zenlabs Ethica Limited | 585.63 Million INR | -27.338% |
| Makers Laboratories Limited | 1.03 Billion INR | 28.132% |
| Lactose (India) Limited | 1.13 Billion INR | 34.522% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -67.17% |
| Roopa Industries Limited | 715.53 Million INR | -4.219% |
| PANJON LTD. | 125.52 Million INR | -494.107% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 88.474% |
| Crestchem Limited | 212.56 Million INR | -250.829% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -13331.718% |
| PRAVEG LIMITED | 915.96 Million INR | 18.586% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 78.581% |
| Norris Medicines Limited | 56.35 Million INR | -1223.244% |
| Denis Chem Lab Limited | 1.67 Billion INR | 55.564% |
| Veerhealth Care Limited | 142.13 Million INR | -424.666% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 47.471% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -88.115% |
| Godavari Drugs Limited | 1.56 Billion INR | 52.414% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -66602.057% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 57.223% |
| Vivanza Biosciences Limited | 278.89 Million INR | -167.39% |
| Medi-Caps Limited | 265.63 Million INR | -180.734% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -105.575% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 40.766% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 56.088% |
| Bharat Parenterals Limited | 2.59 Billion INR | 71.253% |
| BDH Industries Limited | 858.31 Million INR | 13.117% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -624.867% |
| Coral Laboratories Limited | 836.6 Million INR | 10.862% |
| Evoq Remedies Limited | 63.09 Million INR | -1082.008% |
| Trinity League India Limited | 2.95 Million INR | -25178.949% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 52.018% |
| Auro Laboratories Limited | 526.99 Million INR | -41.506% |